ArticleInternational ophthalmology2026
The floppy thyroid eye disease.
Article in International ophthalmology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeTo report unique clinical features and management challenges in patients with co-existing Thyroid Eye Disease (TED) and Floppy Eyelid Syndrome (FES).
methodsRetrospective, multicentric, interventional case series of 9 patients presenting as TED with FES over a period of eight years.
resultsSeventeen eyes with co-existing TED and FES were analysed. The average age at presentation was 51.5 years. There were five males and four females in the cohort. Hypothyroidism and hyperthyroidism were noted in four cases each, while a single patient was euthyroid at presentation. The average exophthalmometry value was 25.5 mm (range, 22-30 mm). All but one had bilateral presentation. Of the 17 eyes, 13 (76%) had episodes of spontaneous globe luxation. Eleven eyes (65%) had congestive signs or surface exposure, which mimicked clinically active TED. Lash ptosis was observed in six (35%) eyes. All (100%) eyes had significant lower eyelid retraction (LER) with inferior scleral show. Upper eyelid retraction was absent in 14 (82%) eyes. Of the six cases where orbital imaging was available, fat-predominant disease was seen in nine orbits.
conclusionTED and FES can rarely co-exist. The lax or ptotic upper eyelid tends to mask upper eyelid retraction, with LER being a more obvious sign. Spontaneous globe luxation may be more common in this cohort, warranting early orbital decompression. Congestive signs and corneal exposure may mimic clinically active TED, potentially leading to corticosteroid misuse.
Indexed as
Identifiers
41729409What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.